Drug regimen found effective for common kidney condition

Share this article:
Drug regimen found effective for common kidney condition
Drug regimen found effective for common kidney condition

A major clinical trial out of the United Kingdom points a new direction for treating a common form of kidney disease.

Researchers at the University of Bristol's Academic Renal Unit looked at three different treatment approaches for a kidney problem called membranous nephropathy. The condition causes small blood vessels in the kidney to become inflamed and can lead to kidney failure in almost half of patients. Kidney failure treatments cost $40 billion in the United States in 2008.

The UK research team found that six months of therapy that involved alternating monthly cycles of prednisolone, a corticosteroid, and chlorambucil, an alkylating agent generally used to treat cancer, was the most effective option. In the study of 108 participants, 33 received prednisolone and chlorambucil, 37 received ciclosporin, and 38 had supportive therapy alone. The randomized controlled trial was done in 37 renal units across the UK.

Managing kidney function is a growing concern for long-term care facilities. Membranous nephropathy leads to end-stage renal disease in more than 20% of patients, researchers said. In the U.S., more than 871,000 people were being treated for end-stage renal disease at the end of 2009. 

The study, “Immunosuppression for progressive membranous nephropathy,” appeared in The Lancet Jan. 9. It was conducted by the Medical Research Council, Novartis, and the Renal Association and Kidney Research UK.

Share this article:

More in News

Skilled nursing facilities with poor quality ratings do not readmit more patients to hospitals, researchers find

Skilled nursing facilities with poor quality ratings do ...

Low-quality and high-quality skilled nursing facilities readmit about the same proportion of residents to hospitals, suggest research findings recently published in the American Journal of Medical Quality.

Cipro and related antibiotics increase MRSA risk in long-term care facilities, study ...

Long-term care residents on a fluoroquinolone antibiotic such as Cipro are at an increased risk for methicillin-resistant Staphylococcus aureus, researchers in France have found.

Jonathan Blum, who oversaw long-term care reforms, resigns as head of Medicare

The nation's top Medicare official, Jonathan Blum, is leaving his post next month, news outlets reported Tuesday. Blum became a familiar figure to long-term care providers through Open Door Forum calls and other outreach efforts during his five-year tenure, as he guided implementation of Medicare ...